Expression patterns of 17β-hydroxysteroid dehydrogenase 14 in human tissues

Hormone and Metabolic Research

Volumn 44, Issue 13, 2012, Pages 949-956

  Sivik, T ^a   Vikingsson, S ^a   Green H ^a,b   Jansson, A ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

17 HSD; immunohistochemistry; radio HPLC

Indexed keywords

ANDROSTENEDIONE; ANTIBODY; ESTRADIOL; ESTRONE; PRASTERONE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; CELL STRAIN HEK293; ENZYME LOCALIZATION; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROID METABOLISM; TISSUE DISTRIBUTION; VALIDATION STUDY;

17-HYDROXYSTEROID DEHYDROGENASES; ANTIBODY SPECIFICITY; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 84871246210     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1321815     Document Type: Article

References (37)

1. Haeseleer F., Palczewski K. Short-chain dehydrogenases/reductases in retina. Meth Enzymol: 2000; 316 372 383
2. Lukacik P., Keller B., Bunkoczi G., Kavanagh K. L., Lee W. H., Adamski J., Oppermann U. Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity. Biochem J: 2007; 402 419 427
3. Sherbet D. P., Guryev O. L., Papari-Zareei M., Mizrachi D., Rambally S., Akbar S., Anchus R. J. Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17beta-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells. Endocrinology: 2009; 150 4154 4162
4. Sonneveld E., Riteco JA C., Jansen H. J., Pieterse B., Brouwer A., Schoonen W. G., van der Burg B. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Toxicol Sci: 2006; 89 173 187
5. Day J. M., Tutill H. J., Purohit A., Reed M. J. Design and validation of specific inhibitors of 17b-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis. Endocr Rel Cancer: 2008; 15 665 692
6. Luu-The V., Bélanger A., Labrie F. Androgen biosynthetic pathways in the human prostate. Best Practice and Research. Clin Endocrinol Metab: 2008; 22 207 221
7. Brereton P., Suzuki T., Sasano H., Li K., Duarte C., Obeyesekere V., Haeseleer F., Palczewski K., Smith I., Komesaroff P., Krozowski Z. Pan1b (17βHSD11)-enzymatic activity and distribution in the lung. Mol Cell Endocrinol: 2001; 171 111 117
8. Geissler W. M., Davis D. L., Wu L., Bradshaw K. D., Patel S., Mendonca B. B., Elliston K. O., Wilson J. D., Russell D. W., Andersson S. Male pseudohermaphroditism caused by mutations of testicular 17-beta-hydroxysteroid dehydrogenase-3. Nature Gen: 1994; 7 34 39
9. Akinola L. A., Poutanen M., Peltoketo H., Vihko R., Vihko P. Characterization of rat 17b-hydroxysteroid dehydrogenase type 1 gene and mRNA transcripts. Gene: 1998; 208 229 238
10. Wu L., Einstein M., Geissler W. M., Chan H. K., Elliston K. O., Andrsson S. Expression cloning and characterization of human 17-beta-hydroxysteroid dehydrogenase type-2, a microsomal-enzyme possessing 20-alpha-hydroxysteroid dehydrogenase-activity. J Biol Chem: 1993; 268 12964 12969
11. Biswas M. G., Russell D. W. Expression cloning and characterization of oxidative 17beta- and 3alpha-hydroxysteroid dehydrogenases from rat and human prostate. J Biol Chem: 1997; 272 15959 15966
12. Markus M., Husen B., Leenders F., Seedorf U., Jungblut P. W., Hall P. H., Adamski J. Peroxisomes contain an enzyme with 17 beta-estradiol dehydrogenase, fatty acid hydratase/dehydrogenase, and sterol carrier activity. Ann N Y Acad Sci: 1996; 804 691 693
13. Moon Y. A., Horton J. D. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J Biol Chem: 2003; 278 7335 7343
14. Krazeisen A., Breitling R., Imai K., Fritz S., Moller G., Adamski J. Determination of cDNA, gene structure and chromosomal localization of the novel human 17beta-hydroxysteroid dehydrogenase type 7(1). FEBS Lett: 1999; 460 373 379
15. Shafqat N., Marschall H. U., Filling C., Nordling E., Wu X. Q., Bjork L., Thyberg J., Martensson E., Salim S., Jornvall H., Oppermann U. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/ 17beta/20beta/21-HSD. Biochem J: 2003; 376 49 60
16. Zhang M., Chen W., Smith S. M., Napoli J. L. Molecular characterization of a mouse short chain dehydrogenase/reductase active with all-trans-retinol in intact cells, mRDH1. J Biol Chem: 2001; 276 44083 44090
17. Labrie F., Belanger A., Simard J., LuuThe V., Labrie C. DHEA and peripheral androgen and estrogen formation: Intracrinology. In: Bellino F. L., Daynes R. A., Hornsby P. J., Lavrin D. H., Nestler J. E. (eds.). Dehydroepiandrosterone. New York New York Acad Sciences: 1995; 1628
18. Oduwole O. O., Li Y., Isomaa V. V., Mäntyniemi A., Pulkka A. E., Soini Y., Vihko P. T. 17b-Hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer. Cancer Res: 2004; 64 7604 7609
19. Gunnarsson C., Jerevall P. L., Hammar K., Olsson B., Nordenskjöld B., Jansson A., Stål O. Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer. Breast Cancer Res Treatment: 2008; 108 35 41
20. Sivik T., Vikingsson S., Gréen H., Jansson A. A validated and rapid high-performance liquid chromatography method for the quantification of conversion of radio-labelled sex steroids. Horm Mol Biol Clin Invest: 2010; 3 375 381
21. Jansson A. K., Gunnarsson C., Cohen M., Sivik T., Stål O. 17b-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer. Cancer Res: 2006; 66 11471 11477
22. Sivik T., Gunnarsson C., Fornander T., Nordenskjold B., Skoog L., Stal O., Jansson A. 17beta-hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer. PLoS One: 2012; 7 e40568
23. Sasano H., Frost A. R., Saitoh R., Harada N., Poutanen M., Vihko R., Bulun S. E., Silverberg S. G., Nagura H. Aromatase and 17b-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metabol: 1996; 81 4042 4046
24. Speirs V., Walton D. S., Hall M. C., Atkin S. L. In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6. Br J Cancer: 1999; 81 690 695
25. Speirs V., Green A. R., Atkin S. L. Activity and gene expression of 17beta-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8. J Steroid Biochem Mol Biol: 1998; 67 267 274
26. Sano T., Hirasawa G., Takeyama J., Darnel A. D., Suzuki T., Moriya T., Kato K., Sekine H., Ohara S., Shimosegawa T., Nakamura J., Yoshihama M., Harada N., Sasano H. 17 beta-Hydroxysteroid dehydrogenase type 2 expression and enzyme activity in the human gastrointestinal tract. Clin Sci (Lond): 2001; 101 485 491
27. English M. A., Hughes S. V., Kane K. F., Langman M. J., Stewart P. M., Hewison M. Oestrogen inactivation in the colon: analysis of the expression and regulation of 17beta-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer. Br J Cancer: 2000; 83 550 558
28. Azzarello J., Fung K. M., Lin H. K. Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system. J Histochem Cytochem: 2008; 56 853 861
29. Sakurai N., Miki Y., Suzuki T., Watanabe K., Narita T., Ando K., Yung TM C., Aoki D., Sasano H., Handa H. Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12. J Steroid Biochem Mol Biol: 2006; 99 174 181
30. Chai Z., Brereton P., Suzuki T., Sasano H., Obeyesekere V., Escher G., Saffery R., Fuller P., Enriquez C., Krozowski Z. 17β-hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells. Endocrinology: 2003; 144 2084 2091
31. Azzarello J. T., Lin H. K., Gherezghiher A., Zakharov V., Yu Z., Kropp B. P., Culkin D. J., Penning T. M., Fung K. M. Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor. Int J Clin Exp Pathol: 2009; 3 147 155
32. Cascio C., Russo D., Drago G., Galizzi G., Passantino R., Guarneri R., Guarneri P. 17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res: 2007; 85 166 172
33. Baker M. E. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action. Mol Cell Endocrinol: 2001; 171 211 215
34. Biswas M. G., Russell D. W. Expression cloning and characterization of oxidative 17 beta- and 3 alpha-hydroxysteroid dehydrogenases from rat and human prostate. J Biol Chem: 1997; 272 15959 15966
35. Haller F., Moman E., Hartmann R. W., Adamski J., Mindnich R. Molecular framework of steroid/retinoid discrimination in 17beta-hydroxysteroid dehydrogenase type 1 and photoreceptor-associated retinol dehydrogenase. J Mol Biol: 2010; 399 255 267
36. Saijo K., Collier J. G., Li A. C., Katzenellenbogen J. A., Glass C. K. An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell: 2011; 145 584 595
37. Khan N., Sharma K. K., Andersson S., Auchus R. J. Human 17beta-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cells. Arch Biochem Biophys: 2004; 429 50 59